Company Announcements

Awards under Deferred Share Plan

Source: RNS
RNS Number : 0679Y
Mpac Group PLC
03 May 2019
 

3 May 2019

 

Mpac Group plc

("Mpac" or the "Company")

Awards under Deferred Share Plan

 

Mpac Group plc announces that on 1 May 2019 its Executive Directors were granted the following share awards as nil-cost options over ordinary shares of 25p each in the Company under the Company's Deferred Share Plan:

 

Director                                  Position                                  Number of Options Granted

Dr A Steels                             Chief Executive                                                            35,409

Mr W C Wilkins                     Group Finance Director                                             33,407

 

Further details relating to the operation of the Deferred Share Plan can be found within the Company's Annual Report and Accounts which are available on the Company's website.

 

Set out below are the notifications, made in accordance with the requirements of the EU Market Abuse Regulation, in relation to the grant of options.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr A Steels - Chief Executive

2

Reason for the notification

a)

Position/status

See 1(a) above - Dr Steels is classified as a PDMR of the Company

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Conditional award of ordinary shares pursuant to the rules of the Company's Deferred Share Plan.

For the award to vest, Dr Steels must remain in employment for three years from the award date.  The rights of the shares are deferred, such that any dividends and other distributions attaching to the shares between the date of the award and the realisation date do not form part of the award.

The stated number of shares will be granted to the director at any time requested by the director from the third anniversary of the date of grant to, normally, the fourth anniversary.  In exceptional circumstances and at the Company's discretion, the Company may make a cash payment of a sum equivalent to the value of the shares that would otherwise have been granted.  In certain circumstances, for example retirement, the director may exercise a proportion of an award before the third-year anniversary of the conditional grant.

c)

Price(s) and volume(s)

Volume(s): Nil cost options over 35,409 shares

 

Price: £Nil

 

 

d)

Aggregated information

-      Volume

 

-      Price

 

-      Total

N/A

e)

Date of the transaction

1 May 2019

f)

Place of the transaction

Outside a trading volume

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr W C Wilkins - Group Finance Director

2

Reason for the notification

a)

Position/status

See 1(a) above - Mr Wilkins is classified as a PDMR of the Company

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Conditional award of ordinary shares pursuant to the rules of the Company's Deferred Share Plan.

For the award to vest, Mr Wilkins must remain in employment for three years from the award date.  The rights of the shares are deferred, such that any dividends and other distributions attaching to the shares between the date of the award and the realisation date do not form part of the award.

The stated number of shares will be granted to the director at any time requested by the director from the third anniversary of the date of grant to, normally, the fourth anniversary.  In exceptional circumstances and at the Company's discretion, the Company may make a cash payment of a sum equivalent to the value of the shares that would otherwise have been granted.  In certain circumstances, for example retirement, the director may exercise a proportion of an award before the third-year anniversary of the conditional grant.

c)

Price(s) and volume(s)

Volume(s): Nil cost options over 33,407 shares

 

Price: £Nil

 

 

d)

Aggregated information

-      Volume

 

-      Price

 

-      Total

N/A

e)

Date of the transaction

1 May 2019

f)

Place of the transaction

Outside a trading volume

 

For further information, please contact:

Mpac Group plc                                                                                                                Tel: +44 (0) 2476 421100

Duncan Tyler, Company Secretary

 

Panmure Gordon (UK) Limited (Nominated Advisor & Broker)   Tel: +44 (0) 20 7886 2500

Dominic Morley

James Stearns

 

Hudson Sandler                                                                                                                Tel: +44 (0) 20 7796 4133

Nick Lyon

Nick Moore


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBDGDURBGBGCX